Chatrin Chatrin
Impact in
- Physiology top 10%
- Calcium signaling and nucleotide metabolism
-
- PARP inhibition in cancer therapy
Papers in
- Oncology 9
- PARP inhibition in cancer therapy 9
-
- Ubiquitin and proteasome pathways 5
- RNA modifications and cancer 4
- RNA and protein synthesis mechanisms 1
- Co-authors
- Lori Buetow (4 shared papers)Syed Feroj Ahmed (4 shared papers)Danny T. Huang (4 shared papers)Mads Gabrielsen (2 shared papers)Gary Sibbet (2 shared papers)Ivan Ahel (8 shared papers)Brian O. Smith (3 shared papers)Kang Zhu (7 shared papers)
- Journals
- The EMBO Journal (2 papers)Science Advances (2 papers)eLife (2 papers)Nucleic Acids Research (2 papers)Nature Structural & Molecular Biology (1 paper)
- Partner nations
- United KingdomFranceChina
In The Last Decade
Chatrin Chatrin
11 papers receiving 263 citations
Peers
Comparison fields: 5 of 37
- Physiology 37
- Oncology 171
- Molecular Biology 187
- Immunology 44
- Epidemiology 50
Countries citing papers authored by Chatrin Chatrin
This map shows the geographic impact of Chatrin Chatrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chatrin Chatrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chatrin Chatrin more than expected).
Fields of papers citing papers by Chatrin Chatrin
This network shows the impact of papers produced by Chatrin Chatrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chatrin Chatrin. The network helps show where Chatrin Chatrin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chatrin Chatrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 67 | |
| 2 | 2020 | 55 | |
| 3 | 2023 | 39 | |
| 4 | 2023 | 28 | |
| 5 | 2024 | 24 | |
| 6 | 2024 | 13 | |
| 7 | 2024 | 12 | |
| 8 | 2017 | 11 | |
| 9 | 2025 | 8 | |
| 10 | 2024 | 7 | |
| 11 | 2025 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2025 | 0 |
About Chatrin Chatrin
Chatrin Chatrin is a scholar working on Oncology, Molecular Biology, Epidemiology, Physiology and Electrical and Electronic Engineering, having authored 13 papers that have together received 265 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (9 papers), Ubiquitin and proteasome pathways (5 papers), Calcium signaling and nucleotide metabolism (4 papers), RNA modifications and cancer (4 papers), Autophagy in Disease and Therapy (4 papers), Integrated Circuits and Semiconductor Failure Analysis (2 papers), HIV Research and Treatment (1 paper) and RNA and protein synthesis mechanisms (1 paper). The work is most often cited by research in Physiology (37 citations), Oncology (171 citations), Molecular Biology (187 citations), Immunology (44 citations) and Epidemiology (50 citations). Chatrin Chatrin has collaborated with scholars based in United Kingdom, France and China. Frequent co-authors include Lori Buetow, Syed Feroj Ahmed, Danny T. Huang, Mads Gabrielsen, Gary Sibbet, Ivan Ahel, Brian O. Smith, Kang Zhu, Sara Zanivan and Marcin J. Suskiewicz. Their work appears in journals such as The EMBO Journal, Science Advances, eLife, Nucleic Acids Research and Nature Structural & Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.